Oppenheimer reiterated their outperform rating on shares of Zimmer Biomet (NYSE:ZBH – Free Report) in a report published on Wednesday morning, Benzinga reports. Oppenheimer currently has a $157.00 price target on the medical equipment provider's stock. Several other research firms have also recently weighed in on ZBH. JMP Securities reissued a market outperform rating and […] The post Zimmer Biomet's (ZBH) 'Outperform' Rating Reiterated at Oppenheimer first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/06/zimmer-biomets-zbh-outperform-rating-reiterated-at-oppenheimer.html

#dailypolitical